Sunstone
How psychedelic-assisted therapy may complement ongoing mental health care
As psychedelic-assisted therapies continue advancing through clinical research, understanding how they fit within existing mental health care systems is increasingly important.
The Intersection of Mystery and Meaning: Dr. Manish Agrawal on the “Death And” Podcast
What happens when an oncologist and a mortician discuss the mystery of death? Dr. Manish Agrawal joins the Death And podcast to bridge the gap between clinical rigor and human mystery. From the "collusion of denial" to the "infinity" found between birth and death, discover how psychedelic-assisted care invites patients back into their own experience to find peace and connection.
Dr. Manish Agrawal Discusses the “Collusion of Denial” in Cancer Care on Great Day Washington
Dr. Manish Agrawal, CEO of Sunstone Therapies, joined Great Day Washington to discuss adjustment disorder—a common but frequently overlooked emotional response to serious illnesses like cancer, MS, and Parkinson’s. While modern medicine excels at treating physical symptoms, Dr. Agrawal highlights the "collusion of denial" that often leaves patients to navigate emotional upheaval in silence. Learn how Sunstone is addressing this critical gap through the REKINDLE Phase 2 study, an innovative clinical trial evaluating an investigational treatment for psychological distress in patients facing life-altering diagnoses.
National Geographic Health Highlights the Potential of Psilocybin in End-of-Life Cancer Care
National Geographic recently highlighted emerging research on psilocybin-assisted therapy for patients facing advanced cancer and end-of-life distress. The article explores how psychedelic-assisted therapy may help reduce depression, anxiety, and existential suffering when delivered within structured clinical settings.
Advancing standards in MDMA psychedelic therapy research training
We are setting the industry standard for high quality training for mental health professionals in psychedelic therapy research.
Research explores how psilocybin-assisted group therapy addresses existential distress in cancer patients
New findings that deepen understanding of how psilocybin-assisted group therapy can help people with cancer and depression.
Podcast | Dr. Manish Agrawal with Healing Cancer Journeys
Blending Science, Story, and the Human Side of Healing October, 2025 — Sunstone Therapies CEO Dr. Manish Agrawal joined Dan […]
Sunstone’s 2Dose Study: Advancing psilocybin-assisted therapy in cancer care
This clinical trial will explore whether psilocybin is more effective than an active placebo and if two doses are better than one.
Research Highlights Meaning-Centered Psychotherapy as Promising Partner for Psilocybin Therapy in Cancer Care
A new paper published in Psychedelic Medicine introduces a novel model combining Meaning-Centered Psychotherapy (MCP) with psilocybin-assisted therapy (PAT) for patients with advanced cancer and depression. Developed from Sunstone Therapies’ investigator-initiated trial, the approach—called MCP-PSIL—aims to help patients reduce distress and find deeper meaning while navigating serious illness.
The paradox of setting expectations for psychedelic therapy
In psychedelic therapy clinical research, setting clear expectations is paramount.
Advancing Psychedelic-Assisted Therapy: Insights from Sunstone’s Latest Research
Co-founder and CEO, Dr. Manish Agrawal, recently shared his expertise and vision for the future of psychedelic-assisted therapy in oncology in a four-part interview series with Pharmacy Times' Lead Editor, Alana Hippensteele.
Previous studies on DMT at Sunstone Therapies
Sunstone is pleased to begin enrollment of two clinical studies exploring the therapeutic potential of DMT (N,N-dimethyltryptamine) and its analogs.